Marijuana Remains the Enemy of U.S. Health Agencies
There's arguably no industry generating more excitement right now than legal marijuana. Last year, Canada became the first industrialized country in the world to legalize the use of recreational cannabis, with 33 U.S. states also giving the green light to medical marijuana since 1996. What had once been a completely taboo topic has become relatively mainstream throughout North America and much of Europe.
Of course, what investors are really waiting for is some form of change at the federal level in the United States. The U.S. is projected to be the leading cannabis market in the world in terms of future sales -- and it's not even close right now. Bank of America/Merrill Lynch and Stifel foresee U.S. weed sales accounting for 33% to 50% of global revenue, which would make the U.S. the most lucrative marijuana market in the world for businesses and investors.
We've also witnessed soaring support for legalization. The October 2018 Gallup poll found that 2 out of 3 Americans now favor broad-based legalization, up from just 25% a quarter-century earlier. Further, a separate survey from the independent Quinnipiac University showed that better than 9 out of 10 support the idea of physicians being able to prescribe medical cannabis to patients.
Source Fool.com
